Orthotic Devices Market Outlook 2030 | Orthotic Devices Market Trends

DelveInsight launched a new report on ‘Orthotic Devices -Market Insights, Competitive Landscape and Market Forecast - 2025’. The report will deliver an in-depth understanding of Orthotic Devices and the historical and forecasted Orthotic Devices market trends in the US, EU5 (Germany, Spain, Italy, France and United Kingdom) and Japan.

The Orthotic Devices market report provides an overview of Orthotic Devices, reasons to get Orthotic Devices as well as its advantages and limitations.

Additionally, the report provides insight on the Orthotic Devices market share of the individual Orthotic Devices devices, current and forecasted Orthotic Devices market size from 2017 to 2025 segmented by seven major markets.

The report also covers the market drivers, market barriers and unmet medical needs to curate best of the opportunities and assesses underlying potential of the market.

Click here and get access to a free sample copy of our report.

What are Orthotic Devices?

Orthotic devices, also known as orthoses, are the braces which allow support to the weakened muscles while walking. They help in order to improve the comfort and aid in slow progress of contractures (the tightened muscles or tendons which tend to become shorter over a period of time). Orthotic devices can be worn at any instance during might or day. The use of a particular type of orthotic device depends on the type of patient’s muscular dystrophy and the kind of muscles that are affected. Different types of orthotic devices include the ankle-foot orthoses and the knee-ankle foot orthoses.

Orthotic is a support, brace, or splint used to support, align, prevent, or correct the function of movable parts of the body. Other orthotics include neck braces, lumbosacral supports, knee braces, and wrist supports. Orthotic devices are particularly beneficial for the patients suffering from arthritis, musculoskeletal and orthopedic ailments, deformities and abnormal posture alignment. These devices are applied externally and can help correct any abnormalities or biomechanical alignment of the body. Due to increases in the geriatric population vulnerable to osteoporosis, osteoarthritis, and other bone diseases, the incidence of bone fractures, and sports-related injuries has risen. Significant rise in various technology advances in the healthcare sector will lead to growth of the market However, cost of custom made orthotic devices will hinder the growth of the market.

These devices have been customized for every individual and are usually constructed of a metal or plastic.

• On the basis of type, the orthotic device market is segmented into rigid, semi-soft and soft orthotics.

• Based on the product type, the orthotic device market is segmented into cervical/spinal orthotics (cervical orthotics, thoracic orthotics and others) upper extremity orthotics (elbow orthoses, shoulder-elbow orthoses and others) and lower extremity orthotics (knee orthotics, foot orthotics and others).

• Based on the patient type, the orthotic device market is segmented into adult and pediatric patients.

• The major end-users for orthotic device are pharmacies, orthotic clinics, and others.

Key pharma players that are working extensively for the development of Orthotic Devices:

· Acor Orthopaedic, Inc.

· Aextrex Worldwide, Inc.

· Deroyal Industries, Inc.

· DJO Global

· Alcare Co.

· Aspen Medical Products, Inc.

· Basko Healthcare

· Bauerfeind

· Becker Orthopedic

· Biomet Inc.

Orthotic Devices Market Insights:

• According to the market research study by DelveInsight, the Orthotic Device market in 7MM is estimated to be XX million in 2026.

• The overall market size for Orthotic Device in the United States is anticipated to rise from XX million in 2018 and reach up to XX million by 2026, growing at a CAGR of XX%.

•      The major end-users for Orthotic Device are pharmacies, orthotic clinics and others.

•      The United State market across 7MM is estimated to contribute maximum share of XX%, followed by EU5 with XX%.

Orthotic Devices Market Landscape

The Orthotic Devices market is segmented by type, product type, patient type and end user. It has presence of major players in the market such as Zimmer, Abilitech and Acor orthopaedics, among others across 7MM. The market is consolidated with many devices owing to rise in chronic joint pain and surge in bone injuries.

The Orthotic Devices market is expected to be driven by the factors such as technological advancement in orthotic device, rising demand for non-invasive pain management procedures, and growing burden of old age population, who are more prone to develop joint and bone disorders. However, high cost of the custom made devices is likely to hamper the market growth.

“The overall market size for Orthotic Device in the United State is anticipated to rise from XX million in 2018 and reach up to XX million by 2026, growing at a CAGR of XX%.”

Request for sample pages: https://www.delveinsight.com/sample-request/orthotic-devices-market

Comments

Post a Comment

Popular posts from this blog

Tenosynovial Giant Cell Tumors (TSGCTs) Market Research Report 2030 | Tenosynovial Giant Cell Tumors (TSGCTs) Market

Image
Tenosynovial Giant Cell Tumors   are a type of neoplasm that affects synovial-lined tendon sheaths, synovial joints, and surrounding soft tissue. Locally aggressive benign tissue lesions are defined by synovial lining inflammation in joints and tendons. Overexpression of the colony-stimulating factor 1 receptor is thought to cause these tumors to form. Giant cell tumors of the tendon sheath (GCTTS), pigmented villonodular tumors (PVNTS), extra-articular pigmented villonodular tumors of the tendon sheath, and localized or focal nodular synovitis are all terms used to describe TSGCTs. Tenosynovial Giant Cell Tumors Causes Translocation is an alteration to a chromosome that causes Tenosynovial Giant Cell Tumors. A chromosome segment breaks off and moves around. The cause of these translocations is unknown. The genetic code for making proteins is stored on chromosomes. A protein termed colony-stimulating factor 1 is produced in excess due to the translocation (CSF1). This protein attracts
Read more

Functional Dyspepsia Market Research Report 2030 | Functional Dyspepsia Market

Image
  Functional dyspepsia   is a term for recurring signs and symptoms of indigestion that have no apparent cause. Functional dyspepsia is also called non-ulcer stomach pain or non-ulcer dyspepsia. It's not clear what causes functional dyspepsia. Doctors consider it a functional disorder, which means that routine testing may not show any abnormalities. Hence, it is diagnosed based on symptoms. Functional Dyspepsia Signs and Symptoms  Functional dyspepsia is common and can be long-lasting — although signs and symptoms are mostly intermittent. These signs and symptoms resemble those of an ulcer, discomfort in your upper abdomen, often accompanied by bloating, belching, and nausea, An early feeling of fullness (satiety) when eating, Pain in the stomach that may sometimes occur unrelated to meals, or maybe relieved with meals. Functional Dyspepsia Epidemiology According to an article by Madisch et al. (2018), Functional Dyspepsia is one of the common functional disorders, with a prevalenc
Read more

Fibrodysplasia Ossificans Progressiva Market Research Report 2030 | Fibrodysplasia Ossificans Progressiva Market

Image
  Fibrodysplasia ossificans progressiva   is a disorder in which the skeleton, muscles, and connective tissues, such as tendons and ligaments, are replaced by bone (ossified). This position was to lead to the formation of the bones of the skeleton (extra-skeletal or heterotopic bone) that constrains movement. Fibrodysplasia ossificans progressiva Causes Fibrodysplasia ossificans progressiva is called a mutation in the ACVR1 gene. This gene is involved in bone growth and development. Mutations, and the possibility of a disorderly development. The gene can be inherited from a parent, but in most cases, the, is a new mutation, a person with a less-than-a family history of the disease. As a parent, they have a 50% chance of passing it on to their children. Fibrodysplasia ossificans progressiva Sign and Symptoms The  Fibrodysplasia ossificans progressiva  symptoms begin in the first decade of life with episodes of painful inflammatory soft tissue swellings. Gradually, there occurs restricti
Read more